Flonase Purchasers Win Class Cert. In Suit Against GSK
A federal judge has granted class certification to direct purchasers of allergy drug Flonase in an antitrust suit against GlaxoSmithKline PLC alleging that the company filed "baseless" petitions with the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article